James F Donohue

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Sensitive Detection

Top Venues

International journal of chronic obstructive pulmonary disease

Journal of healthcare leadership

Pulmonary therapy

This page only lists publications with an associated author ORCID identifier.

Publications

James F Donohue, Tara Rheault, Margot MacDonald-Berko, Thomas Bengtsson, Kathleen Rickard
Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD. International journal of chronic obstructive pulmonary disease 18 (2023)
James F Donohue, J Stuart Elborn, Peter Lansberg, Afzal Javed, Solomon Tesfaye, Hope Rugo, Sita Ratna Devi Duddi, Niraksha Jithoo, Pai-Hui Huang, Kannan Subramaniam, Nagendra Ramanjinappa, Arkady Koltun, Shari Melamed, Juliana Chung Ngor Chan
Bridging the "Know-Do" Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation Science. Journal of healthcare leadership 15 (2023)
James F Donohue, Douglas S Burgoyne, Jonathan K Ward, Richard Allan, Arkady Koltun, Andrew Cooper
Wixela Inhub: A Generic Equivalent Treatment Option for Patients with Asthma or COPD. Pulmonary therapy 7 (1) (2020)
James F Donohue, Ayca Ozol-Godfrey, Thomas Goodin, Shahin Sanjar
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies. International journal of chronic obstructive pulmonary disease 15 (2020)
Dave Singh, Anthony D D'Urzo, James F Donohue, Edward M Kerwin, Eduard Molins, Ferran Chuecos, Anna Ribera, Diana Jarreta
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD. International journal of chronic obstructive pulmonary disease 14 (2019)
James F Donohue, Donald A Mahler, Sanjay Sethi
Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD. International journal of chronic obstructive pulmonary disease 14 (2019)